SARS-CoV-2 variants, spike mutations and immune escape-Reference-Cited by-同舟云学术

SARS-CoV-2 variants, spike mutations and immune escape

Published:2021-06-01 Issue:7 Volume:19 Page:409-424
ISSN:1740-1526
Container-title:Nature Reviews Microbiology
language:en
Short-container-title:Nat Rev Microbiol

Author:

Harvey William T.^ORCID,Carabelli Alessandro M.^ORCID,Jackson Ben^ORCID,Gupta Ravindra K.,Thomson Emma C.,Harrison Ewan M.,Ludden Catherine,Reeve Richard^ORCID,Rambaut Andrew^ORCID,Peacock Sharon J.,Robertson David L.^ORCID,

Publisher

Springer Science and Business Media LLC

Subject

General Immunology and Microbiology,Microbiology,Infectious Diseases

Link

http://www.nature.com/articles/s41579-021-00573-0.pdf

Reference104 articles.

1. WHO. Coronavirus (COVID-19) Dashboard. https://covid19.who.int/ (2021).

2. Meredith, L. W. et al. Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study. Lancet Infect. Dis. 20, 1263–1272 (2020).

3. Rambaut, A. et al. Preliminary Genomic Characterisation of an Emergent SARS-CoV-2 Lineage in the UK Defined by a Novel set of Spike Mutations. https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563 (2020).

4. Frost, S. D. W., Magalis, B. R. & Kosakovsky Pond, S. L. Neutral theory and rapidly evolving viral pathogens. Mol. Biol. Evol. 35, 1348–1354 (2018).

5. MacLean, O. A., Orton, R. J., Singer, J. B. & Robertson, D. L. No evidence for distinct types in the evolution of SARS-CoV-2. Virus Evol. https://doi.org/10.1093/ve/veaa034 (2020).

Cited by 2891 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 infection of domestic animals and their role in evolution and emergence of variants of concern;New Microbes and New Infections;2024-12

2. Dynamic expedition of leading mutations in SARS-CoV-2 spike glycoproteins;Computational and Structural Biotechnology Journal;2024-12

3. Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions;European Journal of Medicinal Chemistry;2024-11

4. Nirmatrelvir and molnupiravir maintain potent in vitro and in vivo antiviral activity against circulating SARS-CoV-2 omicron subvariants;Antiviral Research;2024-10

5. Computational Analysis of the Accumulation of Mutations in Therapeutically Important RNA Viral Proteins During Pandemics with Special Emphasis on SARS-CoV-2;Journal of Molecular Biology;2024-10